18Fluorine fluorodeoxyglucose-positron emission tomography/computed tomography in dermatomyositis

Joint Bone Spine

Volumn 75, Issue 4, 2008, Pages 508-510

  Kim, Hyun Sook ^a   Kim, Chung Ho ^b   Park, Young Ha ^b   Kim, Wan Uk ^c  

^a Chosun University College of Medicine   (South Korea)

^b Dongguk University College of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AUTOIMMUNE DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DELTOID MUSCLE; DERMATOMYOSITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; INFLAMMATION; INFRASPINATUS MUSCLE; LETTER; MALE; MOLECULAR IMAGING; MUSCLE BIOPSY; POSITRON EMISSION TOMOGRAPHY; SARTORIUS MUSCLE; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY;

DERMATOMYOSITIS; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 46749133581     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.12.002     Document Type: Letter

References (9)

1. Callen J.P. Dermatomyositis. Lancet 355 (2000) 53-57
2. Duet M., Pouchot J., Lioté F., et al. Role for positron emission tomography in skeletal diseases. Joint Bone Spine 74 (2007) 14-23
3. Yamada S., Kubota K., Kubota R., et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 36 (1995) 1301-1306
4. Zhao S., Kuge Y., Tsukamoto E., et al. Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: effects of insulin and glucose loading. Nucl Med Commun 23 (2002) 545-550
5. Horger M., and Bares R. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease. Semin Nucl Med 36 (2006) 286-294
6. Hill C.L., Zhang Y., Sigurgeirsson B., et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357 (2001) 96-100
7. Buchbinder R., and Hill C.L. Malignancy in patients with inflammatory myopathy. Curr Rheumatol Rep 4 (2002) 415-426
8. Berner U., Menzel C., Rinne D., et al. Paraneoplastic syndromes: detection of malignant tumors using [(18)F]FDG-PET. Q J Nucl Med 47 (2003) 85-89
9. Liau N., Ooi C., Reid C., et al. F-18 FDG PET/CT detection of mediastinal malignancy in a patient with dermatomyositis. Clin Nucl Med 32 (2007) 304-305